Shanghai unveils steps to build sci-tech innovation corridor in Yangtze River Delta

SHANGHAI, Dec. 29, 2025 /PRNewswire/ — A news report from english.shanghai.gov.cn A…

GEEKOM Returns to CES 2026 with Premium Laptops and Next-Generation Mini PCs

TAIPEI, Dec. 29, 2025 /PRNewswire/ — GEEKOM will make its fourth consecutive appearance at…

Global Times: Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era receives high recognition from intl community: 2025 Global Survey on Impression and Understanding of China

BEIJING, Dec. 29, 2025 /PRNewswire/ — In 2025, the world is undergoing…

ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange

Thai investors now can trade in real-time during local market hours using…

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

SHANGHAI, Dec. 29, 2025 /PRNewswire/ — Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become…

Alphamab Oncology Announces IND Application for a Phase II Clinical Study of HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 as First-line Treatment of Advanced Cervical Cancer was Officially Accepted by CDE

SUZHOU, China, Dec. 29, 2025 /PRNewswire/ — Alphamab Oncology (Stock Code: 9966.HK)…

JA Solar Ranked No. 1 Global Solar Module Manufacturer by Wood Mackenzie

BEIJING, Dec. 29, 2025 /PRNewswire/ — JA Solar, a trusted global partner…

XPENG-Peking University Collaborative Research Accepted by AAAI 2026: Introducing a Novel Visual Token Pruning Framework for Autonomous Driving

XPENG-PKU Research Breakthrough: XPENG, in collaboration with Peking University, has developed FastDriveVLA—a…